(2018) Cutaneous anaplastic large cell lymphoma in a multiple sclerosis patient receiving Fingolimod. Multiple Sclerosis and Related Disorders. pp. 121-123. ISSN 2211-0356 (Electronic) 2211-0348 (Linking)
|
Text
1179.pdf Download (249kB) | Preview |
Abstract
BACKGROUND: Previous reports of cutaneous neoplastic lesions secondary to Fingolimod treatment among multiple sclerosis patients. OBJECTIVE: Reporting a case of cutaneous large cell lymphoma in a multiple sclerosis patient during Fingolimod treatment. METHOD: Case study. RESULT: Our patient developed CD30+ cutaneous large cell lymphoma two years after initiation of Fingolimod treatment and her symptoms regressed following the cessation of treatment. CONCLUSION: This report indicates that cutaneous lymphoid neoplasms should be considered a possible side effect among patients receiving Fingolimod.
| Item Type: | Article |
|---|---|
| Keywords: | Cutaneous large cell lymphoma Fingolimod Multiple sclerosis Side effect |
| Divisions: | Faculty of Medicine > Departments of Clinical Sciences > Department of Neurology Isfahan Neurosciences Research Center |
| Page Range: | pp. 121-123 |
| Journal or Publication Title: | Multiple Sclerosis and Related Disorders |
| Journal Index: | Pubmed, ISI |
| Volume: | 19 |
| Identification Number: | https://doi.org/10.1016/j.msard.2017.11.012 |
| ISSN: | 2211-0356 (Electronic) 2211-0348 (Linking) |
| Depositing User: | مهندس مهدی شریفی |
| URI: | http://eprints.mui.ac.ir/id/eprint/1179 |
Actions (login required)
 |
View Item |